The Eastern Oregon Cancer Center (EOCC) has announced plans to continue operations into early 2026, reversing previous expectations of a closure. This decision comes after the facility faced significant financial challenges, including rising expenses and low reimbursement rates from the Oregon Health Plan and Medicare.
Earlier this year, EOCC had indicated that it would shut down by the end of February 2026, citing factors such as wage inflation and increased operational costs. The center, located in Pendleton, serves as the only provider of radiation therapy in Eastern Oregon, catering to patients from surrounding areas including Baker City, Joseph, Heppner, Irrigon, and Dale/Monument.
Commitment to Patient Care
Since opening its doors in January 2020, EOCC has successfully treated over 1,000 patients. The center’s commitment to providing essential cancer care in a largely underserved region has been crucial for local residents. The recent decision to remain operational is seen as a positive development for patients needing access to radiation therapy.
While the specifics of how EOCC plans to navigate its financial hurdles remain unclear, representatives have expressed optimism about the center’s future. They are currently exploring various solutions to ensure sustainability while continuing to meet the needs of their patients.
Future Developments Expected
As the situation unfolds, further updates from EOCC will provide insight into how the center intends to address its financial challenges while maintaining its vital services. This announcement marks a significant shift in the narrative surrounding cancer care in Eastern Oregon, highlighting the importance of local healthcare facilities in providing critical services to their communities.
More information will be available as the story develops and EOCC outlines its plans for the coming year.
